368 related articles for article (PubMed ID: 30582947)
1. Anti-neurofascin autoantibody and demyelination.
Kira JI; Yamasaki R; Ogata H
Neurochem Int; 2019 Nov; 130():104360. PubMed ID: 30582947
[TBL] [Abstract][Full Text] [Related]
2. Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects.
Manso C; Querol L; Mekaouche M; Illa I; Devaux JJ
Brain; 2016 Jun; 139(Pt 6):1700-12. PubMed ID: 27017186
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy.
Delmont E; Manso C; Querol L; Cortese A; Berardinelli A; Lozza A; Belghazi M; Malissart P; Labauge P; Taieb G; Yuki N; Illa I; Attarian S; Devaux JJ
Brain; 2017 Jul; 140(7):1851-1858. PubMed ID: 28575198
[TBL] [Abstract][Full Text] [Related]
4. Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies.
Koike H; Kadoya M; Kaida KI; Ikeda S; Kawagashira Y; Iijima M; Kato D; Ogata H; Yamasaki R; Matsukawa N; Kira JI; Katsuno M; Sobue G
J Neurol Neurosurg Psychiatry; 2017 Jun; 88(6):465-473. PubMed ID: 28073817
[TBL] [Abstract][Full Text] [Related]
5. Nodal proteins are target antigens in Guillain-Barré syndrome.
Devaux JJ; Odaka M; Yuki N
J Peripher Nerv Syst; 2012 Mar; 17(1):62-71. PubMed ID: 22462667
[TBL] [Abstract][Full Text] [Related]
6. Paranodal lesions in chronic inflammatory demyelinating polyneuropathy associated with anti-Neurofascin 155 antibodies.
Vallat JM; Yuki N; Sekiguchi K; Kokubun N; Oka N; Mathis S; Magy L; Sherman DL; Brophy PJ; Devaux JJ
Neuromuscul Disord; 2017 Mar; 27(3):290-293. PubMed ID: 27986399
[TBL] [Abstract][Full Text] [Related]
7. [The significance of autoantibodies against nodal and paranodal proteins in autoimmune nodopathies].
Ogata H
Rinsho Shinkeigaku; 2023 Nov; 63(11):715-724. PubMed ID: 37880115
[TBL] [Abstract][Full Text] [Related]
8. Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies.
Doppler K; Appeltshauser L; Wilhelmi K; Villmann C; Dib-Hajj SD; Waxman SG; Mäurer M; Weishaupt A; Sommer C
J Neurol Neurosurg Psychiatry; 2015 Jul; 86(7):720-8. PubMed ID: 25694474
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders.
Stathopoulos P; Alexopoulos H; Dalakas MC
Nat Rev Neurol; 2015 Mar; 11(3):143-56. PubMed ID: 25623793
[TBL] [Abstract][Full Text] [Related]
10. Autoantibody responses to nodal and paranodal antigens in chronic inflammatory neuropathies.
Mathey EK; Garg N; Park SB; Nguyen T; Baker S; Yuki N; Yiannikas C; Lin CS; Spies JM; Ghaoui R; Barnett MH; Vucic S; Pollard JD; Kiernan MC
J Neuroimmunol; 2017 Aug; 309():41-46. PubMed ID: 28601286
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies Against the Node of Ranvier in Seropositive Chronic Inflammatory Demyelinating Polyneuropathy: Diagnostic, Pathogenic, and Therapeutic Relevance.
Vural A; Doppler K; Meinl E
Front Immunol; 2018; 9():1029. PubMed ID: 29867996
[TBL] [Abstract][Full Text] [Related]
12. Effect of monovalency on anti-contactin-1 IgG4.
Taieb G; Jentzer A; Vegezzi E; Lleixà C; Illa I; Querol L; Devaux JJ
Front Immunol; 2023; 14():1021513. PubMed ID: 36999029
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype.
Cortese A; Lombardi R; Briani C; Callegari I; Benedetti L; Manganelli F; Luigetti M; Ferrari S; Clerici AM; Marfia GA; Rigamonti A; Carpo M; Fazio R; Corbo M; Mazzeo A; Giannini F; Cosentino G; Zardini E; Currò R; Gastaldi M; Vegezzi E; Alfonsi E; Berardinelli A; Kouton L; Manso C; Giannotta C; Doneddu P; Dacci P; Piccolo L; Ruiz M; Salvalaggio A; De Michelis C; Spina E; Topa A; Bisogni G; Romano A; Mariotto S; Mataluni G; Cerri F; Stancanelli C; Sabatelli M; Schenone A; Marchioni E; Lauria G; Nobile-Orazio E; Devaux J; Franciotta D
Neurol Neuroimmunol Neuroinflamm; 2020 Jan; 7(1):. PubMed ID: 31753915
[TBL] [Abstract][Full Text] [Related]
14. Growing Spectrum of Autoimmune Nodopathies.
Gupta P; Mirman I; Shahar S; Dubey D
Curr Neurol Neurosci Rep; 2023 May; 23(5):201-212. PubMed ID: 37014546
[TBL] [Abstract][Full Text] [Related]
15. Disruption of neurofascin and gliomedin at nodes of Ranvier precedes demyelination in experimental allergic neuritis.
Lonigro A; Devaux JJ
Brain; 2009 Jan; 132(Pt 1):260-73. PubMed ID: 18953054
[TBL] [Abstract][Full Text] [Related]
16. Paranodal and other autoantibodies in chronic inflammatory neuropathies.
Querol L; Illa I
Curr Opin Neurol; 2015 Oct; 28(5):474-9. PubMed ID: 26263474
[TBL] [Abstract][Full Text] [Related]
17. Anti-Neurofascin 155 Antibody-Positive Chronic Inflammatory Demyelinating Polyneuropathy/Combined Central and Peripheral Demyelination: Strategies for Diagnosis and Treatment Based on the Disease Mechanism.
Kira JI
Front Neurol; 2021; 12():665136. PubMed ID: 34177770
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to gliomedin cause peripheral demyelinating neuropathy and the dismantling of the nodes of Ranvier.
Devaux JJ
Am J Pathol; 2012 Oct; 181(4):1402-13. PubMed ID: 22885108
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to the Caspr1/contactin-1 complex in chronic inflammatory demyelinating polyradiculoneuropathy.
Pascual-Goñi E; Fehmi J; Lleixà C; Martín-Aguilar L; Devaux J; Höftberger R; Delmont E; Doppler K; Sommer C; Radunovic A; Carvajal A; Smyth S; Williams L; Mazanec R; Potočková V; Hinds N; Cassereau J; Viala K; Lefilliatre M; Nicolas G; Foley P; Leypoldt F; Keddie S; Lunn MP; Zimprich F; Nunkoo VS; Löscher WN; Martínez-Martínez L; Díaz-Manera J; Rojas-Garcia R; Illa I; Rinaldi S; Querol L
Brain; 2021 May; 144(4):1183-1196. PubMed ID: 33880507
[TBL] [Abstract][Full Text] [Related]
20. Distinguish CIDP with autoantibody from that without autoantibody: pathogenesis, histopathology, and clinical features.
Tang L; Huang Q; Qin Z; Tang X
J Neurol; 2021 Aug; 268(8):2757-2768. PubMed ID: 32266541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
